Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin.

Dooley KE, Luetkemeyer AF, Park JG, Allen R, Cramer Y, Murray S, Sutherland D, Aweeka F, Koletar SL, Marzan F, Bao J, Savic R, Haas DW, AIDS Clinical Trials Group A5306 Study Team
Antimicrob Agents Chemother. 2014 58 (9): 5245-52

PMID: 24957823 · PMCID: PMC4135849 · DOI:10.1128/AAC.03332-14

MeSH Terms (18)

Adult Alkynes Antitubercular Agents Antiviral Agents Benzoxazines Cyclopropanes Drug Combinations Drug Therapy, Combination Female Humans Lopinavir Male Middle Aged Nitroimidazoles Pharmacogenetics Rifampin Ritonavir Young Adult

Connections (1)

This publication is referenced by other Labnodes entities:

Links